Rick Gonzalez, AbbVie CEO
AbbVie bets that nearly $20B in deals can bring it into the post-Humira future
The owner of the world’s biggest drug has finally answered the question about what to do when that product goes away.
Within the space of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
